ai-in-healthcare
(26)
Stacy Simpson Is Marketing What Technology Gives Back
After a career spent translating complicated technology, athenahealth CMO Stacy Simpson has arrived at a deceptively simple measure for AI: does it return time, attention, and clarity to the people using it?
Senan Ebrahim
Senan Ebrahim is the founder and CEO of Delfina, a San Francisco digital health company using AI and data science to improve pregnancy care and close gaps in maternal health. A physician-scientist with an MD and a PhD in computational neuroscience from Harvard, he founded Delfina after witnessing a preventable stillbirth during medical training. He earlier founded Hikma Health, a nonprofit building free health-data tools for refugee and low-income patients. Delfina raised a $17M Series A in early 2025 led by U.S. Venture Partners.
Stas Sokolin
Stas Sokolin is the co-founder and CEO of Amae Health, a specialty integrated-care company for people with severe mental illness. A former impact investor at the Chan Zuckerberg Initiative with earlier stints at Google X and the American Medical Association's Health2047, he started his career as an investment banking analyst at BNP Paribas before setting out to rebuild how the hardest cases in behavioral health are treated - using in-person clinics, multidisciplinary teams, and a data platform built on Palantir. In November 2025 Amae raised a $25 million Series B led by Altos Ventures, pushing its total funding past $50 million.
Dushyant Mishra
Dushyant Mishra is the founder and CEO of RapidClaims, a New York-based company building an AI-first platform for healthcare revenue cycle management. After nearly five years in commercial operations at Abbott and two years as an early-stage investor at Together Fund, he started RapidClaims in 2023 with co-founders Abhinay Vyas and Jot Sarup Singh to attack the roughly $350 billion administrative burden in US healthcare. The company automates medical coding, clinical documentation, claim scrubbing and denial recovery across 25+ specialties, has raised about $11 million including an $8 million Series A led by Accel, and grew roughly sixfold in its first year.
Eric Rock
Eric Rock is the co-founder and CEO of Percipio Health, a Dallas-based company using AI and an ordinary smartphone - no medical devices - to collect whole-person health signals for scalable population health monitoring. A serial healthcare and technology entrepreneur, Rock previously founded ProHost (acquired by OpenTable), MEDHOST (a pioneering touchscreen emergency-department EMR), and Vivify Health, which grew into one of the largest remote patient monitoring platforms before Optum acquired it. Percipio launched in 2025 with $20M in Series A funding and a mission to bring proactive, low-cost care to entire populations.
Niamh O'Hara
Niamh O'Hara is the co-founder and CEO of Biotia, a New York healthtech company that pairs next-generation DNA sequencing with AI to identify pathogens causing hard-to-diagnose infections. An evolutionary biologist by training, she spun the company out of Cornell Tech with Weill Cornell geneticist Christopher Mason, runs a CLIA-certified metagenomics lab in Long Island City, and is building what she calls a global microbial sequence database to catch outbreaks before they spread.
Sanchit Mullick
Sanchit Mullick is the co-founder and CEO of Reveal HealthTech, a New York-based AI transformation firm for U.S. healthcare and life sciences that closed a $7.2M Series A led by Leo Capital in September 2025. Before Reveal, he spent nearly two decades at Infosys, ending as global head of sales for AI & Automation, then led private-equity sales at GlobalLogic. He built Reveal in 2023 with clinician Dr. Salim Afshar and Andrew Bravo, incubated by W Health Ventures and 2070 Health, around two products: BioCanvas for multimodal clinical AI and Prism AI for workflow agents.
Tzvia Bader
Tzvia Bader is the CEO and co-founder of Leal Health (formerly TrialJectory), a New York-based, AI-powered decision support platform that matches cancer patients with FDA-approved treatments and clinical trials. A serial entrepreneur with roughly two decades in tech, she previously led a global business unit at Amdocs and founded startups Vocativ and KIDDOapp before turning to oncology after losing her mother to lymphoma and later facing her own melanoma diagnosis. She built Leal around a simple, insistent idea: patients, not geography or insurance, should decide which treatments they can reach.
Justin Holland
Justin Holland is the co-founder and CEO of HealthJoy, a Chicago-based digital health company that turns the maze of employee benefits into a single AI-guided app. An MIT-trained engineer and serial entrepreneur with two prior exits (OpenInstall to AVG/Avast and FreeCause to Rakuten), he started HealthJoy in 2014 after a personal run-in with the American healthcare system left him unable to find out what his own care would cost. He has led the company for more than a decade, raised roughly $108M in venture financing through a Series D, and built a platform now used by hundreds of thousands of members to navigate care, cut costs, and reach a virtual assistant named JOY.
Michael Prokopis
Michael Prokopis is the CEO of DARVIS, a Houston-based AI and computer vision company that gives hospitals real-time visibility into their inventory. A former Navy Surface Warfare Officer and Gulf War veteran turned healthcare supply chain executive, he spent 25+ years managing more than $3.2 billion in spend and driving $360M+ in savings at institutions including MD Anderson Cancer Center and Steward Health Care before crossing to the other side of the table to run the technology company he once wanted to buy from.
Maria Szandrach
Maria Szandrach is the co-founder and CEO of Mentalyc, a San Francisco clinical-intelligence platform that turns recorded therapy sessions into insurance-ready notes, treatment plans, and progress insights for psychotherapists. A McKinsey strategy alum with an MSc from London Business School, she has co-founded three startups across the mental health and insurance worlds. She built Mentalyc with engineer Georgi Urumov during the COVID pandemic after the two met through Entrepreneur First, later going through Berkeley SkyDeck. Maria has become a recognizable voice on what AI should and should not do inside the therapy room, arguing for slow, careful building in a field where over-promising is dangerous.
Rich Vogel
Rich Vogel is the US CEO of Nervio, an Israeli HealthTech startup building the first AI platform designed specifically for intraoperative neurophysiological monitoring (IONM). A board-certified neurophysiologist with PhDs in both neuroscience and psychology, Vogel is a two-time elected president of the American Society of Neurophysiological Monitoring (ASNM) and one of the most widely recognized voices in the field. He has given more than a thousand talks across clinical, academic, and professional audiences, and now leads Nervio's push to turn raw streams of surgical brain-and-spine signals into real-time alerts that help operating-room teams catch neurologic risk earlier.
Sema Sgaier
Sema Sgaier is the co-founder and CEO of Surgo Health, a Washington, DC public benefit corporation that uses AI and behavioral science to decode the 'why' behind health behaviors. A trained molecular biologist and neuroscientist turned serial entrepreneur, she spent a dozen years at the Bill & Melinda Gates Foundation scaling HIV-prevention programs across India and Africa before co-founding Surgo Foundation, Surgo Ventures, and Surgo Health. She has authored more than 60 peer-reviewed papers, taught at Harvard and the University of Washington, writes op-eds for The New York Times, and is a trained documentary photographer.
Veera Anantha
Veera Anantha is the co-founder and CEO of Constant Therapy Health, a Boston-based digital therapeutics company whose AI-powered app helps people living with stroke, traumatic brain injury, aphasia and other neurological conditions rebuild speech, language and cognitive skills. A trained engineer and physicist with a PhD from Northwestern and a degree from IIT Bombay, he spent years building products at startups acquired by Apple and Motorola before turning to brain rehabilitation. Under his leadership the platform has delivered well over 100 million therapy exercises, creating what is described as the largest real-world brain rehabilitation dataset, and he champions AI that is accountable and explainable enough for healthcare.
Charles R. Bridges
Charles R. Bridges, M.D., Sc.D., is Executive Vice President and Chief Scientific Officer at CorVista Health, where he leads the science behind a machine-learning cardiac diagnostic platform. A cardiac surgeon turned engineer-executive, he holds an A.B. in applied physics from Harvard, an M.D. from Harvard Medical School (which he entered at 18), and both an M.S. in electrical engineering and a D.Sc. in chemical engineering from MIT. He was the first African American full professor of surgery at the University of Pennsylvania, served as a technology chief at Johnson & Johnson's Janssen, and in 2022 was elected to the U.S. National Academy of Engineering. His record spans 175 peer-reviewed publications, 15 patents, and more than $10 million in continuous NIH funding.
Harry DiFrancesco
Harry DiFrancesco is the CEO and co-founder of Carda Health, a New York-based virtual care company rebuilding heart and lung rehabilitation for the home. A philosopher turned coder turned operator, he taught with Teach For America, helped found a school, did business operations at Stripe, and started Carda in 2020 after caring for a parent who could not access prescribed recovery care. He blends human clinicians with AI to remove friction from care delivery, and runs ultramarathons and climbs mountains in his spare time.
Meena Mallipeddi
Meena Mallipeddi is the co-founder and CEO of AmplifyMD, an EHR-integrated, multi-specialty virtual care platform and national physician network that helps hospitals close specialist coverage gaps. Raised in a family of doctors and trained as a Stanford honors grad, Cambridge Gates Scholar, and a 15-year technology and healthcare equity investor, she left the markets to build the company alongside her husband and co-founder, Anand Nathan. Since founding in 2019, AmplifyMD has grown to 300+ programs across 150+ clinical sites, a network of nearly 300 physicians, and 15+ specialties, raising $43M total including a $20M Series B in 2025 led by Forerunner Ventures.
Shashi Shankar
Shashi Shankar is the co-founder and CEO of Novellia, a New York-based, AI-enabled health data platform that turns patients' scattered medical records into clean, longitudinal stories that biopharma companies can actually use. After nearly a decade at Genentech and Roche, he started Novellia in response to his grandfather's death from cancer, when his family found there was no single place to see the man's complete medical history. The company raised an $18M Series A led by Spark Capital and Shankar was named to Worth Magazine's 2025 AI & Health Access Pioneer list.
Yoona Kim
Yoona Kim is the co-founder and CEO of Arine, a San Francisco medication intelligence company she started in 2017 with CTO Penjit 'Boom' Moorhead. A pharmacist and health economist by training, Kim built Arine to attack one of medicine's least glamorous and most expensive problems: people getting the wrong drugs, the wrong doses, and the wrong combinations. Arine's AI platform now touches more than 25 million lives across 40-plus health plan clients, and the company says its work has cut hospitalizations by over 40% for clients while shaving care costs by double digits.
Karim Karti
Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.
Sean Mehra
Sean Mehra is the co-founder and CEO of HealthTap, a Sunnyvale-based virtual-first primary and urgent care platform serving millions of Americans across all 50 states. A Yale biomedical engineering graduate and Stanford MBA, Mehra pivoted from aspiring physician to serial tech entrepreneur—building games companies with hundreds of thousands of simultaneous players before co-founding HealthTap during his first year at Stanford business school. Under his leadership as CEO (appointed June 2021), HealthTap has grown to serve over 350 million consumers, partnered with Samsung Health to embed virtual care in millions of Android devices, and launched Dr.A.I., an LLM-powered pre-visit interview system. Mehra also co-founded what is now Yale's TSAI City entrepreneurship incubator.
Eileen Tanghal
Eileen Tanghal is the Founder and General Partner of Black Opal Ventures, a women-led early-stage venture capital firm based in New York investing at the intersection of healthcare and frontier technology. With over 20 years of VC experience spanning corporate venture (Applied Ventures, ARM Holdings), national security investing (In-Q-Tel), and European VC (Amadeus Capital, Kennet Partners), she co-founded Black Opal in 2021 alongside Dr. Tara Bishop - a friend of 30 years from their days as MIT engineering students. The firm raised a $58M debut fund with backing from Eli Lilly, Bank of America, and J.P. Morgan, and invests in companies using AI, bioengineering, and advanced computing to reshape how healthcare is delivered and who can access it.
Genevieve Lemarchal
Genevieve Lemarchal is the Managing Partner of Suncoast Ventures and Head of Healthcare at Expert Dojo, one of Southern California's most active pre-seed venture funds. A serial entrepreneur turned investor, she focuses on early-stage healthcare startups tackling critical gaps in addiction recovery, maternal care, chronic disease management, and digital health. With a portfolio spanning 35+ companies across 7 countries, she champions underrepresented founders - 50% female, 37-43% from underrepresented backgrounds - and hosts the AdVentureous Podcast, where she interviews entrepreneurs and VCs about building companies that matter.
Robert Mittendorff
Dr. Robert Mittendorff is General Partner and Global Head of Healthcare at B Capital, one of the world's leading multi-stage global investment firms with over $6 billion in assets under management. An MD, MBA, and biomedical engineer rolled into one, he brings the rare combination of clinical credibility, operating experience, and investment acumen to healthcare venture capital. He led B Capital's inaugural $500M+ Healthcare Fund I, backing category-defining companies across digital health, medtech, biotech, and AI-driven healthcare from seed to IPO.
Stuart Peterson
Stuart Peterson is the Founder and Managing General Partner of ARTIS Ventures, a San Francisco-based venture capital firm he launched in 2001 that coined and trademarked the term 'TechBio.' A 2017 Forbes Midas List honoree, Peterson led early-stage investments in YouTube (acquired by Google) and StemCentrx (acquired by AbbVie for $10.2 billion - the largest-ever venture-backed life sciences acquisition), and has since focused ARTIS at the convergence of computer science and life science, closing a $200 million TechBio II Fund in December 2023 to back next-generation health and medicine companies deploying AI, machine learning, and deep learning to transform human health.
Hal Paz
Hal Paz (Harold L. Paz, M.D., M.S.) is an Operating Partner at Khosla Ventures, where he focuses on digital healthcare innovation and AI-driven health solutions. A physician-scientist and seasoned health system CEO, he has led multi-billion-dollar enterprises at CVS Health/Aetna, Ohio State University Wexner Medical Center, Penn State Health, and Stony Brook University Medicine. He has served as a medical school dean twice over - first at Robert Wood Johnson, then at Penn State - and has authored over 100 papers on sepsis, ARDS, and medical devices. Now at one of Silicon Valley's most ambitious venture firms, he bridges the worlds of clinical medicine and frontier technology, helping founders navigate the notoriously complex terrain of American healthcare.